Filed: 2/13/2024ACC: 0001104659-24-018785
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 113 equity positions with a total reported market value of $261.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
113
Positions
$261.6K
Total AUM (reported)
14.87M
Total Shares
Allocation by class
COMMON$261.6K100.0%
Portfolio Concentration
Top 3$118.0K45.1%
4–10$76.9K29.4%
11–25$42.5K16.2%
Rest$24.3K9.3%
Top 3 weight
45.1%
Top 10 weight
74.5%
Voting Authority Distribution
Total shares with voting rights: 14.87M
Sole
Full voting authority
14.87M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other113
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings113
Rows:
Calumet Specialty Products Partners, LP
DFNDShares4.33M
TypeSH
Market value$77.3K
29.54%
Sole
4.33M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$21.0K
8.01%
Sole
225K
Shared
0.00
None
0.00
FTAI Aviation Ltd.
DFNDShares425K
TypeSH
Market value$19.7K
7.54%
Sole
425K
Shared
0.00
None
0.00
The Panagram BBB-B CLO ETF
DFNDShares719.37K
TypeSH
Market value$19.0K
7.26%
Sole
719.37K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$15.8K
6.04%
Sole
112.22K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares1.93M
TypeSH
Market value$10.8K
4.11%
Sole
1.93M
Shared
0.00
None
0.00
Ardelyx, Inc.
DFNDShares1.38M
TypeSH
Market value$8.6K
3.27%
Sole
1.38M
Shared
0.00
None
0.00
Ligand Pharmaceuticals Incorporated
DFNDShares115K
TypeSH
Market value$8.2K
3.14%
Sole
115K
Shared
0.00
None
0.00
The Invesco AAA Floating Rate Note ETF
DFNDShares307.02K
TypeSH
Market value$7.8K
3.00%
Sole
307.02K
Shared
0.00
None
0.00
OmniAb Inc.
DFNDShares1.09M
TypeSH
Market value$6.7K
2.56%
Sole
1.09M
Shared
0.00
None
0.00
Viking Therapeutics, Inc.
DFNDShares270.82K
TypeSH
Market value$5.0K
1.93%
Sole
270.82K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares93.65K
TypeSH
Market value$4.7K
1.80%
Sole
93.65K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$3.6K
1.36%
Sole
20.98K
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares251.85K
TypeSH
Market value$3.6K
1.36%
Sole
251.85K
Shared
0.00
None
0.00
Madrigal Pharmaaceuticals, Inc.
DFNDShares14.80K
TypeSH
Market value$3.4K
1.31%
Sole
14.80K
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares97.54K
TypeSH
Market value$2.8K
1.07%
Sole
97.54K
Shared
0.00
None
0.00
CSX Corporation
DFNDShares70K
TypeSH
Market value$2.4K
0.93%
Sole
70K
Shared
0.00
None
0.00
GSK plc
DFNDShares65K
TypeSH
Market value$2.4K
0.92%
Sole
65K
Shared
0.00
None
0.00
Inozyme Pharma, Inc.
DFNDShares564.55K
TypeSH
Market value$2.4K
0.92%
Sole
564.55K
Shared
0.00
None
0.00
The Panagram AAA CLO ETF
DFNDShares92.96K
TypeSH
Market value$2.4K
0.90%
Sole
92.96K
Shared
0.00
None
0.00
Sanofi
DFNDShares47K
TypeSH
Market value$2.3K
0.89%
Sole
47K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares125.45K
TypeSH
Market value$2.1K
0.81%
Sole
125.45K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares221K
TypeSH
Market value$2.0K
0.76%
Sole
221K
Shared
0.00
None
0.00
Coherus Biosciences, Inc.
DFNDShares526.31K
TypeSH
Market value$1.8K
0.67%
Sole
526.31K
Shared
0.00
None
0.00
Cenovus Energy Inc.
DFNDShares95K
TypeSH
Market value$1.6K
0.60%
Sole
95K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet Specialty Products Partners, LPDFND | Common | 4.33M | SH | $77.3K 29.54% | 4.33M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $21.0K 8.01% | 225K | 0.00 | 0.00 |
FTAI Aviation Ltd.DFND | Common | 425K | SH | $19.7K 7.54% | 425K | 0.00 | 0.00 |
The Panagram BBB-B CLO ETFDFND | Common | 719.37K | SH | $19.0K 7.26% | 719.37K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $15.8K 6.04% | 112.22K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 1.93M | SH | $10.8K 4.11% | 1.93M | 0.00 | 0.00 |
Ardelyx, Inc.DFND | Common | 1.38M | SH | $8.6K 3.27% | 1.38M | 0.00 | 0.00 |
Ligand Pharmaceuticals IncorporatedDFND | Common | 115K | SH | $8.2K 3.14% | 115K | 0.00 | 0.00 |
The Invesco AAA Floating Rate Note ETFDFND | Common | 307.02K | SH | $7.8K 3.00% | 307.02K | 0.00 | 0.00 |
OmniAb Inc.DFND | Common | 1.09M | SH | $6.7K 2.56% | 1.09M | 0.00 | 0.00 |
Viking Therapeutics, Inc.DFND | Common | 270.82K | SH | $5.0K 1.93% | 270.82K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 93.65K | SH | $4.7K 1.80% | 93.65K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $3.6K 1.36% | 20.98K | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 251.85K | SH | $3.6K 1.36% | 251.85K | 0.00 | 0.00 |
Madrigal Pharmaaceuticals, Inc.DFND | Common | 14.80K | SH | $3.4K 1.31% | 14.80K | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 97.54K | SH | $2.8K 1.07% | 97.54K | 0.00 | 0.00 |
CSX CorporationDFND | Common | 70K | SH | $2.4K 0.93% | 70K | 0.00 | 0.00 |
GSK plcDFND | Common | 65K | SH | $2.4K 0.92% | 65K | 0.00 | 0.00 |
Inozyme Pharma, Inc.DFND | Common | 564.55K | SH | $2.4K 0.92% | 564.55K | 0.00 | 0.00 |
The Panagram AAA CLO ETFDFND | Common | 92.96K | SH | $2.4K 0.90% | 92.96K | 0.00 | 0.00 |
SanofiDFND | Common | 47K | SH | $2.3K 0.89% | 47K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 125.45K | SH | $2.1K 0.81% | 125.45K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 221K | SH | $2.0K 0.76% | 221K | 0.00 | 0.00 |
Coherus Biosciences, Inc.DFND | Common | 526.31K | SH | $1.8K 0.67% | 526.31K | 0.00 | 0.00 |
Cenovus Energy Inc.DFND | Common | 95K | SH | $1.6K 0.60% | 95K | 0.00 | 0.00 |
Page 1 of 5
…